These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 13367437)

  • 1. Antibacterial effects of some synthetic compounds on V. cholerae and other organisms.
    GUHA AC; LAHIRI SC
    J Indian Med Assoc; 1956 Sep; 27(5):161-7. PubMed ID: 13367437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of antibiotics on antigenic properties of Vibrio comma].
    TEBIAKINA AE; IVANOV VI; GAVRILENKOVA VIu
    Antibiotiki (Mosc); 1958; 3(1):105-10. PubMed ID: 24544827
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of antibiotics and phage combinations on Vibrio cholerae].
    TEBIAKINA AE
    Antibiotiki (Mosc); 1957; 2(2):43-7. PubMed ID: 24544448
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sensitivity of Vibrio comma to various antibiotics].
    TEBIAKINA AE
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Nov; (11):96-9. PubMed ID: 13300907
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibacterial susceptibility/resistance of Vibrio cholerae eltor clinical strains isolated in the Caucasus during the seventh cholera pandemic].
    Savel'ev VN; Babenyshev BV; Savel'eva IV; Vasil'eva OV; Guseva LV; Grizhebovskiĭ GM; Kurbanov ShKh; Asvarov BM; Batyrova BA; Doroshenko IG; Antonenko AD
    Antibiot Khimioter; 2010; 55(5-6):8-13. PubMed ID: 21033468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic sensitiveness of strains of cholera Vibrio isolated during recent epidemic in Calcutta.
    BASU SN; CHATTERJEE SN; LAHIRI DC; MUKHERJEE AM; NEOGY KN
    Indian J Med Res; 1956 Jul; 44(3):393-6. PubMed ID: 13366410
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective and Efficient Elimination of
    Oh YT; Kim HY; Kim EJ; Go J; Hwang W; Kim HR; Kim DW; Yoon SS
    Front Cell Infect Microbiol; 2016; 6():156. PubMed ID: 27900286
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chick embryo as a medium for evaluation of therapeutic effects of antibiotics in experimental cholera].
    TEBIAKINA AE
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Jul; (7):25-31. PubMed ID: 13257787
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro and in vivo antimicrobial efficacy of natural plant-derived compounds against Vibrio cholerae of O1 El Tor Inaba serotype.
    Kim HI; Kim JA; Choi EJ; Harris JB; Jeong SY; Son SJ; Kim Y; Shin OS
    Biosci Biotechnol Biochem; 2015; 79(3):475-83. PubMed ID: 25516242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of medium-chain monoglycerides on intestinal colonisation by Vibrio cholerae or enterotoxigenic Escherichia coli.
    Petschow BW; Batema RP; Talbott RD; Ford LL
    J Med Microbiol; 1998 May; 47(5):383-9. PubMed ID: 9879938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups.
    Chandrasekhar MR; Krishna BV; Patil AB
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1092-7. PubMed ID: 19062701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysis of Vibrio cholerae by thymol.
    BHASKARAN K
    Nature; 1957 Jul; 180(4575):43. PubMed ID: 13451640
    [No Abstract]   [Full Text] [Related]  

  • 13. The characterization of Vibrio cholerae isolated in Kenya in 1983.
    Ichinose Y; Ehara M; Watanabe S; Shimodori S; Waiyaki PG; Kibue AM; Sang FC; Ngugi J; Kaviti JN
    J Trop Med Hyg; 1986 Oct; 89(5):269-76. PubMed ID: 3795327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Virulence of Toxigenic Vibrio cholerae by Anethole through the Cyclic AMP (cAMP)-cAMP Receptor Protein Signaling System.
    Zahid MS; Awasthi SP; Asakura M; Chatterjee S; Hinenoya A; Faruque SM; Yamasaki S
    PLoS One; 2015; 10(9):e0137529. PubMed ID: 26361388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation on streptomycin inhibitors with the aid of a streptomycin-dependent Vibrio comma.
    OLITZKI AL; GODINGER D
    J Gen Microbiol; 1959 Feb; 20(1):54-60. PubMed ID: 13631182
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antimicrobial activity of Morinda morindoides on in vitro growth of vibrio cholerae in Côte d'Ivoire].
    Koffi AE; Yapi HF; Bahi C; Guessend KN; Djaman JA; Guede-Guina F
    Med Trop (Mars); 2010 Feb; 70(1):53-6. PubMed ID: 20337116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibrio cholerae resistant to 2,4-diamino-6,7-diisopropylpteridine (O/129) isolated from patients with enteritis in Ceará, Brazil.
    Hofer E; Reis EM; Quintaes BR; Rodrigues DP; Feitosa IS; Angelo MR; Ribeiro LH
    J Health Popul Nutr; 2001 Mar; 19(1):39-42. PubMed ID: 11394182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antibacterial effect of selected neuroleptics on Vibrio cholerae.
    Kristiansen JE; Gaarslev K
    Acta Pathol Microbiol Immunol Scand B; 1985 Feb; 93(1):49-51. PubMed ID: 2858954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivity of Vibrio and Aeromonas to antibiotics].
    Khaĭtovich AB; Ved'mina EA; Vlasova IV
    Antibiot Khimioter; 1992 Mar; 37(3):10-3. PubMed ID: 1514858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic sensitivity of Vibrio cholerae other than O serotype 1 (so-called NAG vibrios).
    Sanyal SC; Mukherjee S; Sil J
    Indian J Med Res; 1974 Apr; 62(4):491-6. PubMed ID: 4435860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.